These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 38678623

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Carboplatin Inhibits the Progression of Retinoblastoma Through IncRNA XIST/miR-200a-3p/NRP1 Axis.
    Zhao H, Wan J, Zhu Y.
    Drug Des Devel Ther; 2020; 14():3417-3427. PubMed ID: 32904674
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D, Zheng Y.
    Endocr J; 2021 May 28; 68(5):583-597. PubMed ID: 33612561
    [Abstract] [Full Text] [Related]

  • 8. Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor.
    Feng K, Liu Y, Xu LJ, Zhao LF, Jia CW, Xu MY.
    Biomed Pharmacother; 2018 Aug 28; 104():686-698. PubMed ID: 29803929
    [Abstract] [Full Text] [Related]

  • 9. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zheng Y, Xie L, Xu S, Yan W, Zhang H, Meng Y, Liu J, Wei X.
    Mol Cell Biochem; 2021 Nov 28; 476(11):4031-4044. PubMed ID: 34244973
    [Abstract] [Full Text] [Related]

  • 10. lncRNA CCAT1 promotes cell proliferation, migration, and invasion by down-regulation of miR-143 in FTC-133 thyroid carcinoma cell line.
    Yang T, Zhai H, Yan R, Zhou Z, Gao L, Wang L.
    Braz J Med Biol Res; 2018 Nov 28; 51(6):e7046. PubMed ID: 29791590
    [Abstract] [Full Text] [Related]

  • 11. The Effect of LncRNA H19/miR-194-5p Axis on the Epithelial-Mesenchymal Transition of Colorectal Adenocarcinoma.
    Li CF, Li YC, Wang Y, Sun LB.
    Cell Physiol Biochem; 2018 Nov 28; 50(1):196-213. PubMed ID: 30278464
    [Abstract] [Full Text] [Related]

  • 12. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p.
    Hou S, Lin Q, Guan F, Lin C.
    J Cell Biochem; 2018 Nov 28; 119(10):8304-8316. PubMed ID: 29893424
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long non-coding RNA SNHG14 contributes to gastric cancer development through targeting miR-145/SOX9 axis.
    Liu Z, Yan Y, Cao S, Chen Y.
    J Cell Biochem; 2018 Aug 28; 119(8):6905-6913. PubMed ID: 29667771
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. LncRNA H19/miR-29b-3p/PGRN Axis Promoted Epithelial-Mesenchymal Transition of Colorectal Cancer Cells by Acting on Wnt Signaling.
    Ding D, Li C, Zhao T, Li D, Yang L, Zhang B.
    Mol Cells; 2018 May 31; 41(5):423-435. PubMed ID: 29754471
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Overexpression of long intergenic noncoding RNA LINC00312 inhibits the invasion and migration of thyroid cancer cells by down-regulating microRNA-197-3p.
    Liu K, Huang W, Yan DQ, Luo Q, Min X.
    Biosci Rep; 2017 Aug 31; 37(4):. PubMed ID: 28539331
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.